Ortin Labs Reports Flat Performance in Q1 FY25, PAT Decreases by 600%
Ortin Laboratories, a microcap pharmaceutical company, recently announced its financial results for the quarter ending June 2024. The company’s performance for the quarter has been flat, with a score of -3, showing a slight improvement from the previous quarter’s score of -9.
One of the major factors contributing to this flat performance is the company’s Profit After Tax (PAT), which has fallen to -0.10 crore, a decrease of 600% compared to the same quarter last year. This downward trend in PAT is a cause for concern in the near term.
Despite this, Ortin Labs remains committed to its mission of providing affordable and high-quality pharmaceutical products to its customers. The company has a strong presence in the microcap segment of the industry and continues to focus on expanding its product portfolio and market reach.
However, according to MarketsMOJO, a leading financial analysis platform, the stock call for Ortin Labs is currently ‘Sell’. This could be due to the company’s recent financial performance and the overall market conditions. Investors are advised to carefully consider their options before making any investment decisions.
Overall, Ortin Labs’ financial results for the quarter ending June 2024 may not be as promising as expected, but the company remains determined to overcome these challenges and continue its growth trajectory in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
